Live Breaking News & Updates on Wuxi Diagnostics|Page 4

Stay updated with breaking news from Wuxi diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Chinese diagnostics firm WuXi Diagnostics raises $150m in Series B round


Chinese diagnostics firm WuXi Diagnostics raises $150m in Series B round
WuXi Diagnostics has developed a series of COVID-19 detection products. Source: WuXi Diagnostics
February 24, 2021
Chinese integrated diagnostics developer WuXi Diagnostics has raised $150 million in a Series B round of financing to advance its R&D pipeline and open-access innovation enabling platform, as the firm seeks to accelerate its market penetration in the global diagnostics sector.
The Series B round was backed by new investors including Thermo Fisher Scientific, the world’s largest maker of scientific instruments; healthcare-focused investment firm Shiyu Capital; ABC International, a wholly-owned subsidiary of Agricultural Bank of China; Sunland Capital, which focuses on early- and growth-stage healthcare investments; and equity investment fund CCBI Tech Venture. ....

United States , Jack Ma , Jason Liu , Anding Hospital Of Capital Medical University , College Of American Pathologists , Agricultural Bank , Mayo Collaborative Services , Thermo Fisher , Treatment Collaborative Network , Wuxi Diagnostics , Thermo Fisher Scientific , Shiyu Capital , Sunland Capital , Wuxi Apptec , American Pathologists , Mayo Clinic , China Biliary Atresia Diagnosis , Beijing Anding Hospital , Capital Medical University , Lake Bleu Capital , ஒன்றுபட்டது மாநிலங்களில் , பலா மா , ஜேசன் லியூ , அண்டிங் மருத்துவமனை ஆஃப் மூலதனம் மருத்துவ பல்கலைக்கழகம் , கல்லூரி ஆஃப் அமெரிக்கன் நோயியல் நிபுணர்கள் , மயோ கூட்டு சேவைகள் ,

Thermo Fisher Scientific Inc - Consensus Indicates Potential 6.8% Upside


10:10 pm
Thermo Fisher Scientific Inc found using ticker (TMO) now have 19 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The target price ranges between 550 and 260 calculating the average target price we see 500.37. Given that the stocks previous close was at 468.59 this is indicating there is a potential upside of 6.8%. There is a 50 day moving average of 465.39 while the 200 day moving average is 402.98. The market capitalisation for the company is $191,826m. Company Website: http://www.thermofisher.com
Thermo Fisher Scientific Inc. provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services worldwide. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, and diagnosis of diseases to pharmaceutical, biotechn ....

United States , Northeastern University , Daiichi Sankyo , Life Sciences Solutions , Company Website , Its Laboratory Products , Thermo Fisher Scientific Inc , Fisher Scientific , Analytical Instruments , Specialty Diagnostics , Laboratory Products , Wuxi Diagnostics , Mayo Clinic , ஒன்றுபட்டது மாநிலங்களில் , வடகிழக்கு பல்கலைக்கழகம் , தய்ச்சி சாங்கியோ , வாழ்க்கை அறிவியல் தீர்வுகள் , நிறுவனம் இணையதளம் , அதன் ஆய்வகம் ப்ராடக்ட்ஸ் , தெர்மோ மீனவர் அறிவியல் இன்க் , மீனவர் அறிவியல் , பகுப்பாய்வு கருவிகள் , சிறப்பு பரிசோதனை , ஆய்வகம் ப்ராடக்ட்ஸ் , மயோ சிகிச்சையகம் ,